Beta receptor blocker therapy for the elderly in the COVID-19 era

doi:10.12998/wjcc.v10.i23.8088

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4100)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

303

WORD

HTML

2347

Figures (1-1)

304

Tables (1-1)

248

Sum=3275

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

254

Download

571

Sum=825

Aug 16, 2022 (publication date) through May 20, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Aug 16, 2022; 10(23): 8088-8096
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8088

Open in New Tab Full Size Figure Download Figure

Figure 1 Beta blocker therapy for the elderly in the coronavirus disease 2019 scenario. ARDS: Acute respiratory distress syndrome; COPD: Chronic obstructive pulmonary disease; COVID-19: Coronavirus disease 2019; Iv: Intravenous.

Citation: Santillo E, Migale M. Beta receptor blocker therapy for the elderly in the COVID-19 era. World J Clin Cases 2022; 10(23): 8088-8096
URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8088.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8088